Multus Overview
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$300K
- Investors
-
26
Multus General Information
Description
Developer of a biotechnology platform designed to accelerate the development of high-performance cell culture media for biomanufacturing. The company offers AI-driven, high-throughput robotic automation and an expert team of scientists and engineers, enabling biomanufacturers to enhance efficiency, strengthen supply chain reliability, and advance the production of next-generation therapies, food, and materials.
Contact Information
Website
www.multus.bioCorporate Office
- Translation & Innovation Hub
- 84 Wood Lane
- London W12 0BZ
- England, United Kingdom
Corporate Office
- Translation & Innovation Hub
- 84 Wood Lane
- London W12 0BZ
- England, United Kingdom
Multus Timeline
Multus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Accelerator/Incubator | 26-May-2026 | $300K | Completed | Generating Revenue | ||
| 16. Early Stage VC (Series A) | 16-Jan-2023 | Completed | Generating Revenue | |||
| 15. Grant | 23-Mar-2022 | Completed | Generating Revenue | |||
| 14. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 13. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 12. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 11. Seed Round | 19-Jul-2021 | Completed | Generating Revenue | |||
| 10. Grant | 31-Mar-2021 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 8. Grant | 01-Jan-2021 | $150K | Completed | Generating Revenue |
Multus Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A | ||||||||
| Ordinary A | 38,461 | $0.000001 | $4.68 | $4.68 | 1x | $4.68 | 1.87% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Multus Comparisons
Industry
Financing
Details
Multus Competitors (2)
One of Multus’s 2 competitors is InVitria, a Corporation company based in Junction City, KS.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| InVitria | Corporation | Junction City, KS | ||||
| Abcalis | Accelerator/Incubator Backed | Braunschweig, Germany |
Multus Patents
Multus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202218985-D0 | Engineered epidermal growth factor variants | Inactive | 15-Dec-2022 | ||
| EP-4634210-A1 | Engineered platelet-derived growth factor variants | Pending | 15-Dec-2022 | ||
| GB-202218987-D0 | Engineered platelet-derived growth factor variants | Pending | 15-Dec-2022 | ||
| GB-2637896-A | Engineered platelet-derived growth factor variants | Pending | 15-Dec-2022 | ||
| US-20260201004-A1 | Engineered platelet-derived growth factor variants | Pending | 15-Dec-2022 | C07K14/49 |
Multus Signals
Multus Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | Minority | ||
| Asahi Kasei Corporate Venture Capital | Corporate Venture Capital | Minority | ||
| Big Idea Ventures | Venture Capital | Minority | ||
| Mandi Ventures | Venture Capital | Minority | ||
| Nourish Ventures | Corporate Venture Capital | Minority |
Multus FAQs
-
Where is Multus headquartered?
Multus is headquartered in London, United Kingdom.
-
What is the size of Multus?
Multus has 27 total employees.
-
What industry is Multus in?
Multus’s primary industry is Biotechnology.
-
Is Multus a private or public company?
Multus is a Private company.
-
What is Multus’s current revenue?
The current revenue for Multus is .
-
How much funding has Multus raised over time?
Multus has raised $12.9M.
-
Who are Multus’s investors?
MedTech Innovator, Asahi Kasei Corporate Venture Capital, Big Idea Ventures, Mandi Ventures, and Nourish Ventures are 5 of 26 investors who have invested in Multus.
-
Who are Multus’s competitors?
InVitria and Abcalis are competitors of Multus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process